申请人:Burgdorf Lars Thore
公开号:US20090131506A1
公开(公告)日:2009-05-21
The present invention relates to oxindoles of the formula I, their use as protein kinase activators or inhibitors, a method for their manufacture, their use for the preparation of a medicament for the treatment of diseases and their use for the manufacture of a pharmaceutical composition.